Why the study?
Does rho kinase inhibition alter sex-dependent vascular dysfunction in streptozotocin-induced diabetic models?
Does rho kinase inhibition alter sex-dependent vascular dysfunction in streptozotocin-induced diabetic models?
Acute rho kinase inhibition reduces serotonin-induced vascular contractions in diabetic males, but chronic treatment paradoxically increases vasoconstriction, highlighting complex sex-specific vascular mechanisms in diabetes.
Paradoxical acute versus chronic rho kinase effects in diabetic vessels caution against translation; leaves open sex-specific mechanisms for targeted study.
We hypothesized that rho/rho kinase plays a role in sex differences in vascular dysfunction of diabetics. Contractions to serotonin were greater in isolated aortic rings from nondiabetic males versus females and increased further in streptozotocin-induced diabetic males but not females. The increased contractions to serotonin in males were reduced by inhibitors of rho kinase (fasudil, Y27632 and H1152) despite no change in expression of rhoA or rho kinase. Contractions to U46619 were not altered by fasudil or Y27632 or the presence of diabetes. In contrast to acute effects of fasudil, chronic treatment with fasudil increased contractions to serotonin in aorta from both non-diabetic and diabetic males. In summary, serotonin-induced contractions were increased in aorta from diabetic males but not females. Although administration of rho kinase inhibitors acutely decreased contractions to serotonin, long-term treatment with fasudil increased contractions. Long-term fasudil treatment may increase compensatory mechanisms to enhance vasoconstrictions.
No takes yet. Share an insight, caveat, or question.
Nuno et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: